Design and synthesis of the CB1 selective cannabinoid antagonist AM281

R X Lan, Q Lu, P S Fan, J Gatley, N D Volkow, S R Fernando, Roger Guy Pertwee, A Makriyannis

Research output: Contribution to journalArticle

Abstract

In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM281) was synthesized. This compound is an analog of the potent, CB1 receptor selective antagonist SR141716A [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide]. AM281 bound to brain and spleen membrane preparations (CB1 and CB2 receptors, respectively) with K-i values of 12 nM and 4200 nM, respectively. AM281 also inhibited the response of guinea-pig small intestine preparation to a cannabinoid receptor agonist. Thus, AM281 behaves as a CB1 receptor selective antagonist. Methods for the rapid, high-yield synthesis and purification of [I-123]AM281 were developed, and transaxially reconstructed brain SPECT images obtained after continuous infusion of [I-123]AM281 in baboons. Thus [I-123]AM281 may be suitable for imaging CB1 receptors in humans.

Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalAAPS PharmSci
Volume1
Issue number2
DOIs
Publication statusPublished - Jun 1999

Keywords

  • AM281
  • cannabinoid CB1 receptor
  • cannabinoid receptor antagonist
  • CB1 selective ligand
  • SPECT image
  • I-123 LABELED AM251
  • RAT-BRAIN
  • RECEPTOR ANTAGONIST
  • SR 141716A
  • IN-VIVO
  • LOCALIZATION
  • RADIOLIGAND
  • SR141716A
  • BINDING
  • AM281
  • cannabinoid receptor antagonist
  • CB1 selective ligand

Cite this

Lan, R. X., Lu, Q., Fan, P. S., Gatley, J., Volkow, N. D., Fernando, S. R., ... Makriyannis, A. (1999). Design and synthesis of the CB1 selective cannabinoid antagonist AM281. AAPS PharmSci, 1(2), 39-45. https://doi.org/10.1208/ps010204

Design and synthesis of the CB1 selective cannabinoid antagonist AM281. / Lan, R X ; Lu, Q ; Fan, P S ; Gatley, J ; Volkow, N D ; Fernando, S R ; Pertwee, Roger Guy; Makriyannis, A .

In: AAPS PharmSci, Vol. 1, No. 2, 06.1999, p. 39-45.

Research output: Contribution to journalArticle

Lan, RX, Lu, Q, Fan, PS, Gatley, J, Volkow, ND, Fernando, SR, Pertwee, RG & Makriyannis, A 1999, 'Design and synthesis of the CB1 selective cannabinoid antagonist AM281', AAPS PharmSci, vol. 1, no. 2, pp. 39-45. https://doi.org/10.1208/ps010204
Lan RX, Lu Q, Fan PS, Gatley J, Volkow ND, Fernando SR et al. Design and synthesis of the CB1 selective cannabinoid antagonist AM281. AAPS PharmSci. 1999 Jun;1(2):39-45. https://doi.org/10.1208/ps010204
Lan, R X ; Lu, Q ; Fan, P S ; Gatley, J ; Volkow, N D ; Fernando, S R ; Pertwee, Roger Guy ; Makriyannis, A . / Design and synthesis of the CB1 selective cannabinoid antagonist AM281. In: AAPS PharmSci. 1999 ; Vol. 1, No. 2. pp. 39-45.
@article{cda332370b2a4d819de341a44c50e70c,
title = "Design and synthesis of the CB1 selective cannabinoid antagonist AM281",
abstract = "In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM281) was synthesized. This compound is an analog of the potent, CB1 receptor selective antagonist SR141716A [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide]. AM281 bound to brain and spleen membrane preparations (CB1 and CB2 receptors, respectively) with K-i values of 12 nM and 4200 nM, respectively. AM281 also inhibited the response of guinea-pig small intestine preparation to a cannabinoid receptor agonist. Thus, AM281 behaves as a CB1 receptor selective antagonist. Methods for the rapid, high-yield synthesis and purification of [I-123]AM281 were developed, and transaxially reconstructed brain SPECT images obtained after continuous infusion of [I-123]AM281 in baboons. Thus [I-123]AM281 may be suitable for imaging CB1 receptors in humans.",
keywords = "AM281, cannabinoid CB1 receptor, cannabinoid receptor antagonist, CB1 selective ligand, SPECT image, I-123 LABELED AM251, RAT-BRAIN, RECEPTOR ANTAGONIST, SR 141716A, IN-VIVO, LOCALIZATION, RADIOLIGAND, SR141716A, BINDING, AM281 , cannabinoid receptor antagonist , CB1 selective ligand",
author = "Lan, {R X} and Q Lu and Fan, {P S} and J Gatley and Volkow, {N D} and Fernando, {S R} and Pertwee, {Roger Guy} and A Makriyannis",
year = "1999",
month = "6",
doi = "10.1208/ps010204",
language = "English",
volume = "1",
pages = "39--45",
journal = "AAPS PharmSci",
issn = "1522-1059",
publisher = "American Association of Pharmaceutical Scientists",
number = "2",

}

TY - JOUR

T1 - Design and synthesis of the CB1 selective cannabinoid antagonist AM281

AU - Lan, R X

AU - Lu, Q

AU - Fan, P S

AU - Gatley, J

AU - Volkow, N D

AU - Fernando, S R

AU - Pertwee, Roger Guy

AU - Makriyannis, A

PY - 1999/6

Y1 - 1999/6

N2 - In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM281) was synthesized. This compound is an analog of the potent, CB1 receptor selective antagonist SR141716A [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide]. AM281 bound to brain and spleen membrane preparations (CB1 and CB2 receptors, respectively) with K-i values of 12 nM and 4200 nM, respectively. AM281 also inhibited the response of guinea-pig small intestine preparation to a cannabinoid receptor agonist. Thus, AM281 behaves as a CB1 receptor selective antagonist. Methods for the rapid, high-yield synthesis and purification of [I-123]AM281 were developed, and transaxially reconstructed brain SPECT images obtained after continuous infusion of [I-123]AM281 in baboons. Thus [I-123]AM281 may be suitable for imaging CB1 receptors in humans.

AB - In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM281) was synthesized. This compound is an analog of the potent, CB1 receptor selective antagonist SR141716A [N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide]. AM281 bound to brain and spleen membrane preparations (CB1 and CB2 receptors, respectively) with K-i values of 12 nM and 4200 nM, respectively. AM281 also inhibited the response of guinea-pig small intestine preparation to a cannabinoid receptor agonist. Thus, AM281 behaves as a CB1 receptor selective antagonist. Methods for the rapid, high-yield synthesis and purification of [I-123]AM281 were developed, and transaxially reconstructed brain SPECT images obtained after continuous infusion of [I-123]AM281 in baboons. Thus [I-123]AM281 may be suitable for imaging CB1 receptors in humans.

KW - AM281

KW - cannabinoid CB1 receptor

KW - cannabinoid receptor antagonist

KW - CB1 selective ligand

KW - SPECT image

KW - I-123 LABELED AM251

KW - RAT-BRAIN

KW - RECEPTOR ANTAGONIST

KW - SR 141716A

KW - IN-VIVO

KW - LOCALIZATION

KW - RADIOLIGAND

KW - SR141716A

KW - BINDING

KW - AM281

KW - cannabinoid receptor antagonist

KW - CB1 selective ligand

U2 - 10.1208/ps010204

DO - 10.1208/ps010204

M3 - Article

VL - 1

SP - 39

EP - 45

JO - AAPS PharmSci

JF - AAPS PharmSci

SN - 1522-1059

IS - 2

ER -